Custom Antibody Market Growth and Analysis 2028
The custom antibody market was valued at US$ 833.71 million by 2028 from US$ 409.26 million in 2021; it is estimated to grow at a CAGR of 10.7% from 2021 to 2028.
Customized antibodies can be generated in a mouse, rat, or hamster, to meet any host requirements. Companies are providing wide range of antibodies according to the researcher's requirements. There are variety of customized antibodies in the market which includes polyclonal and monoclonal antibody, recombinant monoclonal antibody, hybridoma antibody, polyclonal recombinant antibody, and others. Companies are offering complete support services for all types and steps of antibody production from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification.
The growth of the custom antibody market is attributed to the factors such as the high demand in research, growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are widely enhancing the performance of biotechnology. However, the production for the monoclonal and polyclonal antibodies varies based on the animals being used to derive them. The cost is also determined by the packages of custom antibodies demanded for different applications that are offered by different players hinders the market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Custom Antibody Market: Strategic Insights
Market Size Value in US$ 409.26 Million in 2021 Market Size Value by US$ 833.71 Million by 2028 Growth rate CAGR of 10.7% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Custom Antibody Market: Strategic Insights
| Market Size Value in | US$ 409.26 Million in 2021 |
| Market Size Value by | US$ 833.71 Million by 2028 |
| Growth rate | CAGR of 10.7% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Production and Development Services Offered by Custom Antibody Providers
Various companies are aggressively offering research and development services for custom antibodies. A few of such services launched in by these companies are mentioned below.
- In June 2021, GenScript announced the launch of its MonoRab, a custom rabbit monoclonal antibody (mAB) service. It is added in company’s integrated premium antibody service portfolio. MonoRab is the company’s proprietary technology that utilizes the combination of hybridoma technologies and early-stage monoclonal antibody sequencing. Both technologies delivers custom rabbit mAbs that are more specific and possess higher affinity as well as diversified abilities required for a broad range of applications.
- In March 2021, Giotto Biotech launched specialized polyclonal and monoclonal antibody production services. The company facilitates the production of more than 500 monoclonal antibody types that can be used for diagnostic and therapeutic applications. It offers a large choice of species as the sources of polyclonal antibodies.
- In November 2020, AMSBIO announced development services for rabbit and mouse recombinant monoclonal antibodies. The development of recombinant monoclonal antibodies is based on the DimAb development platform, which is different from conventional hybridoma fusion technologies. It has ability to isolate IgG genes from B cells of immunized animals. These antibodies assist in the development and commercialization of drugs in the market. In October 2019, the FDA approved first rabbit monoclonal antibody-derived drug—Beovu. Beovu is intended to treat wet age-related macular degeneration (AMD).
- In March 2020, Absolute Antibody Ltd announced the launch of high-throughput recombinant antibody production service for its FleXpress. The company offers its customers with services for facilitating the rapid expression of many antibodies, up to a volume of 80 ml scale, as well as for propelling the production capacity to meet rising demands for recombinant antibody technology.
Such custom antibody production services offered by companies are accelerating the market growth.
Service - Based Insights
Based on service, the custom antibody market is segmented into antibody development, antibody production and purification, and antibody fragmentation and labelling. In 2020, the antibody development segment held the largest share of the market, and is estimated to grow at significant CAGR during the forecast period.
Type-based Insights
Based on type, the custom antibody market is segmented into monoclonal antibodies, polyclonal antibodies, and other custom antibodies. In 2020, the monoclonal antibodies segment held the largest share of the market, whereas the polyclonal antibodies segment is expected to grow during the forecast period.
Source -based Insights
Based on source, the custom antibody market is segmented into mice, rabbit, and others. The mice segment held the largest share of the market in 2020, whereas the mice segment is anticipated to register the highest CAGR in the market during the forecast period.
Research Area -based Insights
Based on research area, the custom antibody market is segmented into oncology, immunology, stem cells, infectious disease, neurobiology, cardiovascular disease, and others. The oncology segment held the largest share of the market in 2020, whereas the stem cells segment is anticipated to register the highest CAGR in the market during the forecast period.
End Users-based Insights
Based on end users, the custom antibody market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations. In 2020, the pharmaceutical and biotechnology companies segment held the largest share of the market and is expected to grow at the fastest rate during the coming years.
Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the breast reconstruction market players focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally.
Custom Antibody Market Report Scope
By service
- Antibody Development
- Antibody Production and Purification
- Antibody Fragmentation and Labelling
By Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Other Custom Antibodies
By Source
- Mice
- Rabbits
- Others
By Research Area
- Oncology
- Immunology
- Stem Cells
- Infectious Diseases
- Neurobiology
- Cardiovascular Diseases
- Others
By End Users
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Thermo Fisher Scientific Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- ABCAM
- GenScript
- Rockland Immunochemicals, Inc
- ProMab
- BioLegend, Inc
- Agilent Technologies, Inc
- Cell Signaling Technology, Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Service , Type , Source , and Research Area , End Users , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The growth of the region is attributed to factors such as rising public–private partnerships, and increasing funding activities are widely enhancing the performance of biotechnology Moreover, presence of well-developed healthcare infrastructure and government support are some of the prominent factors propelling the market growth in Asia Pacific. In addition, the Europe is expected account for the fastest growth in the custom antibody market. A high demand in research, growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are widely enhancing the performance of biotechnology growth of Europe custom antibody market during the forecast period.
Customized antibodies can be generated in a mouse, rat or hamster, to meet any particular host requirements. Companies are providing wide range of antibodies according to the researcher's requirements. There are variety of customized antibodies in the market which includes polyclonal and monoclonal antibody, recombinant monoclonal antibody, hybridoma antibody, polyclonal recombinant antibody and others. Companies are offering complete support services for all types and steps of antibody production from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification.
The growth of the market is attributed to some key driving factors such as the high demand in research, growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are widely enhancing the performance of biotechnology. For instance, In January 2021, Morphic Therapeutic, a biotechnology company, collaborated with Janssen Pharmaceutical, Inc., a part of Johnson & Johnson Private Limited, to develop novel antibodies against third integrin target proteins (a family of ubiquitous receptors. Such strategic steps are also projected to drive the market growth.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Custom Antibody Market – By Service
1.3.2 Custom Antibody Market – By Type
1.3.3 Custom Antibody Market – By Source
1.3.4 Custom Antibody Market – By Research Area
1.3.5 Custom Antibody Market – By End User
1.3.6 Custom Antibody Market – By Geography
2. Custom Antibody Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Custom Antibody Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America: PEST Analysis
4.2.2 Europe: PEST Analysis
4.2.3 Asia Pacific: PEST Analysis
4.2.4 Middle East and Africa: PEST Analysis
4.2.5 South and Central America: PEST Analysis
4.3 Expert Opinion
5. Custom Antibody Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Demand in Research
5.1.2 Market Consolidations Strategies Adopted by Biotechnology Companies
5.1.3 Production and Development Services Offered by Custom Antibody Providers
5.2 Market Restraints
5.2.1 High Cost of Production
5.3 Market Opportunities
5.3.1 Proliferation of Biotechnology Industry in Developing Regions
5.4 Future Trends
5.4.1 Developments for Custom Antibodies
5.5 Impact Analysis
6. Custom Antibody Market – Global Analysis
6.1 Global Custom Antibody Marker Revenue Forecast and Analysis
6.2 Global Custom Antibody Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Custom Antibody Market Analysis – By Service
7.1 Overview
7.2 Custom Antibody Market Revenue Share, by Service (2020 and 2028)
7.3 Antibody Development
7.3.1 Overview
7.3.2 Antibody Development: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Antibody Production and Purification
7.4.1 Overview
7.4.2 Antibody Production and Purification: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
7.5 Antibody Fragmentation and Labelling
7.5.1 Overview
7.5.2 Antibody Fragmentation and Labelling: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
8. Custom Antibody Market Analysis – By Type
8.1 Overview
8.2 Custom Antibody Market Revenue Share, by Type (2020 and 2028)
8.3 Monoclonal Antibodies
8.3.1 Overview
8.3.2 Monoclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Polyclonal Antibodies
8.4.1 Overview
8.4.2 Polyclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
8.5 Other Custom Antibodies
8.5.1 Overview
8.5.2 Other Custom Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
9. Custom Antibody Market Analysis – By Source
9.1 Overview
9.2 Custom Antibody Market Revenue Share, By Source (2020 and 2028)
9.3 Mice
9.3.1 Overview
9.3.2 Mice: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Rabbit
9.4.1 Overview
9.4.2 Rabbit: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10. Custom Antibody Market Analysis – By Research Area
10.1 Overview
10.2 Custom Antibody Market Revenue Share, by Research Area (2020 and 2028)
10.3 Oncology
10.3.1 Overview
10.3.2 Oncology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Immunology
10.4.1 Overview
10.4.2 Immunology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Stem Cells
10.5.1 Overview
10.5.2 Stem Cells: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Infectious Disease
10.6.1 Overview
10.6.2 Infectious Disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.7 Neurobiology
10.7.1 Overview
10.7.2 Neurobiology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.8 Cardiovascular Disease
10.8.1 Overview
10.8.2 Cardiovascular disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.9 Others
10.9.1 Overview
10.9.2 Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
11. Custom Antibody Market Analysis – By End User
11.1 Overview
11.2 Custom Antibody Market Revenue Share, by End User (2020 and 2028)
11.3 Pharmaceutical and Biotechnology Companies
11.3.1 Overview
11.3.2 Pharmaceutical and Biotechnology Companies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
11.4 Academic and Research Institutes
11.4.1 Overview
11.4.2 Academic and Research Institutes: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
11.5 Contract Research Organizations
11.5.1 Overview
11.5.2 Contract Research Organizations: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
12. Custom Antibody Market – Geographical Analysis
12.1 North America: Custom Antibody Market Revenue and Forecast to 2028
12.1.1 Overview
12.1.2 North America: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.3 North America: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.1.4 North America: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.1.5 North America: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.1.6 North America: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)
12.1.7 North America: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.1.8 North America: Custom Antibody Market, by Country, 2020 & 2028 (%)
12.1.8.1 US: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.8.1.1 US: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.8.1.2 US: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.1.8.1.3 US: Custom antibody Market, by Type, 2019–2028 (USD Million)
12.1.8.1.4 US: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.1.8.1.5 US: Custom antibody Market, by Research Area, 2019–2028 (USD Million)
12.1.8.1.6 US: Custom antibody Market, by End User, 2019–2028 (USD Million)
12.1.8.2 Canada: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.8.2.1 Canada: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.8.2.2 Canada: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.1.8.2.3 Canada: Custom antibody Market, by Type, 2019–2028 (USD Million)
12.1.8.2.4 Canada: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.1.8.2.5 Canada: Custom antibody Market, by Research Area, 2019–2028 (USD Million)
12.1.8.2.6 Canada: Custom antibody Market, by End User, 2019–2028 (USD Million)
12.1.8.3 Mexico: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.8.3.1 Mexico: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.8.3.2 Mexico: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.1.8.3.3 Mexico: Custom antibody Market, by Type, 2019–2028 (USD Million)
12.1.8.3.4 Mexico: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.1.8.3.5 Mexico: Custom antibody Market, by Research Area, 2019–2028 (USD Million)
12.1.8.3.6 Mexico: Custom antibody Market, by End User, 2019–2028 (USD Million)
12.2 Europe: Custom Antibody Market
12.2.1 Overview
12.2.2 Europe: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.2.3 Europe: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.2.4 Europe: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.2.5 Europe: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.2.6 Europe: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)
12.2.7 Europe: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.2.8 Europe: Custom Antibody Market, by Country, 2020 & 2028 (%)
12.2.8.1 UK: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.2.8.1.1 UK: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.2.8.1.2 UK: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.2.8.1.3 UK: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.2.8.1.4 UK: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.2.8.1.5 UK: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)
12.2.8.1.6 UK: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.2.8.2 Germany: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.2.8.2.1 Germany: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.2.8.2.2 Germany: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.2.8.2.3 Germany: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.2.8.2.4 Germany: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.2.8.2.5 Germany: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)
12.2.8.2.6 Germany: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.2.8.3 France: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.2.8.3.1 France: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.2.8.3.2 France: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.2.8.3.3 France: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.2.8.3.4 France: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.2.8.3.5 France: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)
12.2.8.3.6 France: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.2.8.4 Italy: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.2.8.4.1 Italy: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.2.8.4.2 Italy: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.2.8.4.3 Italy: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.2.8.4.4 Italy: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.2.8.4.5 Italy: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)
12.2.8.4.6 Italy: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.2.8.5 Spain: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.2.8.5.1 Spain: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.2.8.5.2 Spain: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.2.8.5.3 Spain: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.2.8.5.4 Spain: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.2.8.5.5 Spain: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)
12.2.8.5.6 Spain: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.2.8.6 Rest of Europe: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.2.8.6.1 Rest of Europe: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.2.8.6.2 Rest of Europe: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.2.8.6.3 Rest of Europe: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.2.8.6.4 Rest of Europe: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.2.8.6.5 Rest of Europe: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)
12.2.8.6.6 Rest of Europe: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.3 Asia-Pacific Custom Antibody Market Revenue and Forecasts to 2028
12.3.1 Overview
12.3.2 Asia Pacific: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.3.3 Asia Pacific: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.3.4 Asia Pacific: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.3.5 Asia Pacific: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.3.6 Asia Pacific: Custom Antibody Market, by Research area, 2019–2028 (USD Million)
12.3.7 Asia Pacific: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.3.8 Asia Pacific: Custom Antibody Market, by Country, 2020 & 2028 (%)
12.3.8.1 China: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.1.1 China: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.1.2 China: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.3.8.1.3 China: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.3.8.1.4 China: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.3.8.1.5 China: Custom Antibody Market, by Research area, 2019–2028 (USD Million)
12.3.8.1.6 China: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.3.8.2 Japan: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.2.1 Japan: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.2.2 Japan: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.3.8.2.3 Japan: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.3.8.2.4 Japan: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.3.8.2.5 Japan: Custom Antibody Market, by Research area, 2019–2028 (USD Million)
12.3.8.2.6 Japan: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.3.8.3 India: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.3.1 India: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.3.2 India: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.3.8.3.3 India: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.3.8.3.4 India: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.3.8.3.5 India: Custom Antibody Market, by Research area, 2019–2028 (USD Million)
12.3.8.3.6 India: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.3.8.4 South Korea: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.4.1 South Korea: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.4.2 South Korea: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.3.8.4.3 South Korea: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.3.8.4.4 South Korea: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.3.8.4.5 South Korea: Custom Antibody Market, by Research area, 2019–2028 (USD Million)
12.3.8.4.6 South Korea: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.3.8.5 Australia: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.5.1 Australia: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.5.2 Australia: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.3.8.5.3 Australia: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.3.8.5.4 Australia: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.3.8.5.5 Australia: Custom Antibody Market, by Research area, 2019–2028 (USD Million)
12.3.8.5.6 Australia: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.3.8.6 Rest of Asia-Pacific: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.6.1 Rest of Asia-Pacific: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.3.8.6.2 Rest of Asia-Pacific: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.3.8.6.3 Rest of Asia-Pacific: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.3.8.6.4 Rest of Asia-Pacific: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.3.8.6.5 Rest of Asia-Pacific: Custom Antibody Market, by Research area, 2019–2028 (USD Million)
12.3.8.6.6 Rest of Asia-Pacific: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.4 Middle East & Africa: Custom Antibody Market Revenue and Forecasts To 2028
12.4.1 Overview
12.4.2 Middle East and Africa: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.4.3 Middle East and Africa: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.4.4 Middle East and Africa: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.4.5 Middle East and Africa: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.4.6 Middle East and Africa: Custom Antibody Market, by Research area, 2019–2028 (USD Million)
12.4.7 Middle East and Africa: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.4.8 Middle East and Africa: Custom Antibody Market, by Country, 2020 & 2028 (%)
12.4.8.1 Saudi Arabia: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.1.1 Saudi Arabia: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.1.2 Saudi Arabia: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.4.8.1.3 Saudi Arabia: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.4.8.1.4 Saudi Arabia: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.4.8.1.5 Saudi Arabia: Custom Antibody Market, by Research area, 2019–2028 (USD Million)
12.4.8.1.6 Saudi Arabia: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.4.8.2 UAE: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.2.1 UAE: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.2.2 UAE: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.4.8.2.3 UAE: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.4.8.2.4 UAE: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.4.8.2.5 UAE: Custom Antibody Market, by Research area, 2019–2028 (USD Million)
12.4.8.2.6 UAE: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.4.8.3 South Africa: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.3.1 South Africa: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.3.2 South Africa: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.4.8.3.3 South Africa: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.4.8.3.4 South Africa: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.4.8.3.5 South Africa: Custom Antibody Market, by Research area, 2019–2028 (USD Million)
12.4.8.3.6 South Africa: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.4.8.4 Rest of Middle East and Africa: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.4.1 Rest of Middle East and Africa: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.4.8.4.2 Rest of Middle East and Africa: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.4.8.4.3 Rest of Middle East and Africa: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.4.8.4.4 Rest of Middle East and Africa: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.4.8.4.5 Rest of Middle East and Africa: Custom Antibody Market, by Research area, 2019–2028 (USD Million)
12.4.8.4.6 Rest of Middle East and Africa: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.5 South and Central America: Custom antibody Market Revenue and Forecast to 2028
12.5.1 Overview
12.5.2 South and Central America: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.5.3 South and Central America: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.5.4 South and Central America: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.5.5 South and Central America: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.5.6 South and Central America: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)
12.5.7 South and Central America: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.5.8 South and Central America: Custom Antibody Market, by Country, 2020 & 2028 (%)
12.5.8.1 Brazil: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.1.1 Brazil: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.1.2 Brazil: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.5.8.1.3 Brazil: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.5.8.1.4 Brazil: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.5.8.1.5 Brazil: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)
12.5.8.1.6 Brazil: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.5.8.2 Argentina: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.2.1 Argentina: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.2.2 Argentina: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.5.8.2.3 Argentina: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.5.8.2.4 Argentina: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.5.8.2.5 Argentina: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)
12.5.8.2.6 Argentina: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.5.8.3 Rest of South and Central America: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.3.1 Rest of South and Central America: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.5.8.3.2 Rest of South and Central America: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.5.8.3.3 Rest of South and Central America: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.5.8.3.4 Rest of South and Central America: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.5.8.3.5 Rest of South and Central America: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)
12.5.8.3.6 Rest of South and Central America: Custom Antibody Market, by End User, 2019–2028 (USD Million)
13. Impact of COVID-19 Pandemic on Global Custom Antibody Market
13.1 North America: Impact Assessment of COVID-19 Pandemic
13.2 Europe: Impact Assessment of COVID-19 Pandemic
13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
13.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
13.5 South and Central America: Impact Assessment of COVID-19 Pandemic
14. Custom Antibody Market–Industry Landscape
14.1 Overview
14.2 Growth Strategies in the Custom Antibody Market, 2020-2021
14.3 Inorganic Growth Strategies
14.3.1 Overview
14.4 Organic Growth Strategies
14.4.1 Overview
15. Company Profiles
15.1 THERMO FISHER SCIENTIFIC INC.
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 BIO-RAD LABORATORIES INC.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 MERCK KGaA
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 ABCAM
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 GenScript
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Rockland Immunochemicals, Inc
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 ProMab
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 BioLegend, Inc.
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Agilent Technologies, Inc.
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Cell Signaling Technology, Inc.
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
16. Appendix
16.1 About the Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. North America: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 2. North America: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. North America: Custom Antibody Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 4. North America: Custom Antibody Market, by Research Area – Revenue and Forecast to 2028 (USD Million)
Table 5. North America: Custom Antibody Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 6. US: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 7. US: Custom antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. US: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 9. US: Custom antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 10. US: Custom antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 12. Canada: Custom antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 13. Canada: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 14. Canada: Custom antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 15. Canada: Custom antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 17. Mexico: Custom antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Mexico: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 19. Mexico: Custom antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 20. Mexico: Custom antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 21. Europe: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 22. Europe: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 23. Europe: Custom Antibody Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 24. Europe: Custom Antibody Market, by Research Area – Revenue and Forecast to 2028 (USD Million)
Table 25. Europe: Custom Antibody Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 26. UK: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 27. UK: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 28. UK: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 29. UK: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 30. UK: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 31. Germany: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 32. Germany: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 33. Germany: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 34. Germany: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 35. Germany: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 36. France: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 37. France: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 38. France: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 39. France: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 40. France: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 41. Italy: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 42. Italy: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 43. Italy: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 44. Italy: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 45. Italy: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 46. Spain: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 47. Spain: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 48. Spain: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 49. Spain: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 50. Spain: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 51. Rest of Europe: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 52. Rest of Europe: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of Europe: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of Europe: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 55. Rest of Europe: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 56. Asia Pacific Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 57. Asia Pacific Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 58. Asia Pacific Custom Antibody Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 59. Asia Pacific Custom Antibody Market, by Research area – Revenue and Forecast to 2028 (USD Million)
Table 60. Asia Pacific Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 61. China Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 62. China Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 63. China Custom Antibody Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 64. China Custom Antibody Market, by Research area – Revenue and Forecast to 2028 (USD Million)
Table 65. China Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 66. Japan Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 67. Japan Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 68. Japan Custom Antibody Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 69. Japan Custom Antibody Market, by Research area – Revenue and Forecast to 2028 (USD Million)
Table 70. Japan Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 71. India Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 72. India Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 73. India Custom Antibody Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 74. India Custom Antibody Market, by Research area – Revenue and Forecast to 2028 (USD Million)
Table 75. India Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 76. South Korea Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 77. South Korea Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 78. South Korea Custom Antibody Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 79. South Korea Custom Antibody Market, by Research area – Revenue and Forecast to 2028 (USD Million)
Table 80. South Korea Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 81. Australia Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 82. Australia Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 83. Australia Custom Antibody Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 84. Australia Custom Antibody Market, by Research area – Revenue and Forecast to 2028 (USD Million)
Table 85. Australia Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 86. Rest of Asia-Pacific Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 87. Rest of Asia-Pacific Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 88. Rest of Asia-Pacific Custom Antibody Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Asia-Pacific Custom Antibody Market, by Research area – Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of Asia-Pacific Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 91. Middle East and Africa Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 92. Middle East and Africa Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 93. Middle East and Africa Custom Antibody Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 94. Middle East and Africa Custom Antibody Market, by Research area – Revenue and Forecast to 2028 (USD Million)
Table 95. Middle East and Africa Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 96. Saudi Arabia Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 97. Saudi Arabia Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 98. Saudi Arabia Custom Antibody Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 99. Saudi Arabia Custom Antibody Market, by Research area – Revenue and Forecast to 2028 (USD Million)
Table 100. Saudi Arabia Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 101. UAE Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 102. UAE Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 103. UAE Custom Antibody Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 104. UAE Custom Antibody Market, by Research area – Revenue and Forecast to 2028 (USD Million)
Table 105. UAE Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 106. South Africa Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 107. South Africa Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 108. South Africa Custom Antibody Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 109. South Africa Custom Antibody Market, by Research area – Revenue and Forecast to 2028 (USD Million)
Table 110. South Africa Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 111. Rest of Middle East and Africa Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 112. Rest of Middle East and Africa Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 113. Rest of Middle East and Africa Custom Antibody Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 114. Rest of Middle East and Africa Custom Antibody Market, by Research area – Revenue and Forecast to 2028 (USD Million)
Table 115. Rest of Middle East and Africa Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 116. South and Central America: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 117. South and Central America: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 118. South and Central America: Custom Antibody Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 119. South and Central America: Custom Antibody Market, by Research Area – Revenue and Forecast to 2028 (USD Million)
Table 120. South and Central America: Custom Antibody Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 121. Brazil: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 122. Brazil: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 123. Brazil: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 124. Brazil: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 125. Brazil: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 126. Argentina: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 127. Argentina: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 128. Argentina: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 129. Argentina: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 130. Argentina: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 131. Rest of South and Central America: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 132. Rest of South and Central America: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 133. Rest of South and Central America: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 134. Rest of South and Central America: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 135. Rest of South and Central America: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 136. Recent Inorganic Growth Strategies in the Custom Antibody Market
Table 137. Recent Organic Growth Strategies in the Custom Antibody Market
Table 138. Glossary of Terms, Custom Antibody Market
LIST OF FIGURES
Figure 1. Custom Antibody Market Segmentation
Figure 2. Custom Antibody Market – By Geography
Figure 3. Custom Antibody Market Overview
Figure 4. Antibody Development Segment Held Largest Share of Custom Antibody Market by Service
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Custom Antibody Market , by Geography (US$ Million)
Figure 7. Global Custom Antibody Market – Leading Country Markets (US$ Million)
Figure 8. Global Allergy Immunotherapies Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Expert Opinion
Figure 15. Custom Antibody Market Impact Analysis of Drivers and Restraints
Figure 16. Global Custom Antibody Market – Revenue Forecast and Analysis – 2020- 2028
Figure 17. Global Custom Antibody Market – By Geography Forecast and Analysis – 2020- 2028
Figure 18. Market Positioning of Key Players in Global Custom Antibody Market
Figure 19. Custom Antibody Market Revenue Share, by Service (2020 and 2028)
Figure 20. Antibody Development: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. Antibody Production and Purification : Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 22. Antibody Fragmentation and Labelling: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 23. Custom Antibody Market Revenue Share, by Type (2020 and 2028)
Figure 24. Monoclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 25. Polyclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 26. Other Custom Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 27. Custom Antibody Market Revenue Share, by Source (2020 and 2028)
Figure 28. Mice: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Rabbit: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Custom Antibody Market Revenue Share, by Research Area (2020 and 2028)
Figure 32. Oncology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Immunology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Stem Cells: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Infectious Disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Neurobiology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Cardiovascular disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Custom Antibody Market Revenue Share, by End User (2020 and 2028)
Figure 40. Pharmaceutical and Biotechnology Companies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 41. Academic and Research Institutes: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 42. Contract Research Organizations: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 43. North America: Custom Antibody Market , by Key Country – Revenue (2020) (USD Million)
Figure 44. North America Custom Antibody Market Revenue and Forecast to 2028 (USD Million)
Figure 45. North America: Custom Antibody Market , by Country, 2020 & 2028 (%)
Figure 46. US: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. Canada: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. Mexico: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. Europe: Custom Antibody Market , by Key Country – Revenue (2020) (USD Million)
Figure 50. Europe Custom Antibody Market Revenue and Forecast to 2028 (USD Million)
Figure 51. Europe: Custom Antibody Market , by Country, 2020 & 2028 (%)
Figure 52. UK: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 53. Germany: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 54. France: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 55. Italy: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 56. Spain: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 57. Rest of Europe: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. Asia Pacific: Custom Antibody Market, by Key Country – Revenue (2020) (USD Million)
Figure 59. Asia Pacific: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 60. Asia Pacific: Custom Antibody Market, by Country, 2020 & 2028 (%)
Figure 61. China: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 62. Japan: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 63. India: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 64. South Korea: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 65. Australia: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 66. Rest of Asia-Pacific: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. Middle East and Africa: Custom Antibody Market, by Key Country – Revenue (2020) (USD Million)
Figure 68. Middle East and Africa : Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 69. Middle East and Africa: Custom Antibody Market, by Country, 2020 & 2028 (%)
Figure 70. Saudi Arabia: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 71. UAE: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 72. South Africa: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 73. Rest of Middle East and Africa: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 74. South and Central America: Custom Antibody Market , by Key Country – Revenue (2020) (USD Million)
Figure 75. South and Central America Custom Antibody Market Revenue and Forecast to 2028 (USD Million)
Figure 76. South and Central America: Custom Antibody Market , by Country, 2020 & 2028 (%)
Figure 77. Brazil: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 78. Argentina: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 79. Rest of South and Central America: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 80. Impact of COVID-19 Pandemic in North American Country Markets
Figure 81. Impact of COVID-19 Pandemic in European Country Markets
Figure 82. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 83. Impact of COVID-19 Pandemic in Middle East and Africa Market
Figure 84. Impact of COVID-19 Pandemic in South and Central America Market
Figure 85. Growth Strategies in the Custom Antibody Market, 2020-2021
The List of Companies - Custom Antibody Market
- Thermo Fisher Scientific Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- ABCAM
- GenScript
- Rockland Immunochemicals, Inc
- ProMab
- BioLegend, Inc
- Agilent Technologies, Inc
- Cell Signaling Technology, Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For